Clinical Trial Update: The Effect of Intravitreal Ozurdex on DME After Cataract Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intravitreal Ozurdex for diabetic macular edema following cataract surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Diabetic Macular Edema | Phase 3 | Status: COMPLETED